Fennec Pharmaceuticals Inc.
← Back to FENC Overview

Fennec Pharmaceuticals Inc. (FENC)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

265.09

Financial Fundamentals

FENCQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2000-09-30-2.70
2000-12-31-3.33
2001-03-31-2.83
2001-06-30-3.66
2001-09-30-3.33
2001-12-31-5.36
2002-03-31-3.26
2002-06-30-2.00
2002-09-30-2.59
2002-12-31-3.75
2003-03-31-3.53
2003-06-30-2.75
2003-09-30-3.23
2003-12-31-3.09
2004-03-31-4.69
2004-06-30-0.98
2004-09-30-0.90
2004-12-31-96.77
2005-03-31-0.84
2005-06-30-0.57
2005-09-30-0.67
2005-12-31-0.40
2006-03-31-1.38
2006-06-30-0.90
2006-09-30-0.80
2006-12-31-0.54
2007-03-31-1.44
2007-06-30-2.40
2007-09-30-2.88
2007-12-31-2.78
2008-03-31-2.14
2008-06-30-2.40
2008-09-30-2.40
2008-12-31-3.53
2009-03-31-3.61
2009-06-30-7.14
2009-09-30-263.16
2009-12-3144.51
2010-03-31-25.00
2010-06-30-30000.00
2010-09-3016.67
2010-12-31-3.16
2011-03-314.35
2011-06-3055.56
2011-09-30-5.88
2011-12-316.82
2012-03-319.09
2012-06-30-41.78
2012-09-30-33.33
2012-12-31-3.85
2013-03-31-6.12
2013-06-303.85
2013-09-30-14.29
2013-12-3127.27
2014-03-31-9.09
2014-06-30-37.50
2014-09-3075.00
2014-12-3121.43
2015-03-31150.00
2015-06-30-187.50
2015-09-30-265.49
2015-12-31-59.76
2016-03-31-75.00
2016-06-30-50.00
2016-09-30-81.52
2016-12-31-33.52
2017-03-31-50.00
2017-06-30-27.27
2017-09-30-18.48
2017-12-31-15.66
2018-03-31-35.55
2018-06-30-18.64
2018-09-30-14.30
2018-12-31-10.63
2019-03-31-9.42
2019-06-30-4.06
2019-09-30-13.23
2019-12-31-9.01
2020-03-31-7.82
2020-06-30-9.94
2020-09-30-6.31
2020-12-31-13.30
2021-03-31-8.63
2021-06-30-12.15
2021-09-30-14.72
2021-12-31-6.47
2022-03-31-9.33
2022-06-30-7.34
2022-09-30-6.53
2022-12-31-8.00
2023-03-31-7.17
2023-06-30-10.51
2023-09-30-26.82
2023-12-31-28.05
2024-03-315.77
2024-06-30-7.84
2024-09-30-5.95
2024-12-31-21.85
2025-03-31-36.08
2025-06-30-17.29
2025-09-30-102.18
2025-12-31-11.32
2026-03-31265.09

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.

Fennec Pharmaceuticals Inc. (FENC) P/E Ratio History & Valuation Cycles